Source comparison
CJC-1295 Sleep Protocol Comparison
| Protocol Variant | Dosage | Timing | Expected SWS Increase | Cortisol Impact | Best For | Professional Assessment ||—|—|—|—|—|—|| Standard Evening Protocol | 100–150mcg | 2 hours pre-bed | 12–18% | Minimal disruption | Younger subjects with intact GH | Gold
This comparison does not assign a generated winner or score.
- | Protocol Variant | Dosage | Timing | Expected SWS Increase | Cortisol Impact | Best For | Professional Assessment ||—|—|—|—|—|—|| Standard Evening Protocol | 100–150mcg | 2 hours pre-bed | 12–18% | Minimal disruption | Younger subjects with intact GH | Gold standard for first-time use. Lowest effective dose with circadian alignment || High-Dose Loading | 200–300mcg | 2 hours pre-bed, every 3 days × 2 weeks | 18–25% | Slight AM elevation during loading | Older subjects or GH-deficient states | Accelerates therapeutic effect but requires monitoring for joint stiffness || Morning Injection (Misaligned) | 100–200mcg | 8–10 AM | 0–5% | Sustained daytime elevation | None. Contraindicated for sleep | Amplifies wrong pulses; elevates cortisol-dominant phase; fragments sleep || Weekly Maintenance | 100–200mcg | 2 hours pre-bed, once weekly | 10–15% sustained | Negligible | Long-term use after loading phase | Cost-effective; maintains benefit without accumulation risk |